science1 publisher
UCLA engineers a tumor receptor into cord blood stem cells before they mature into T cells
One dose controlled tumor growth in mouse models of ovarian cancer and melanoma. The safety case for the UCLA cells rests on a random receptor repertoire they never build. The work is in Cell Reports Medicine.
Publishers:sciencedaily.com
Reality
- Evidence34
- Adoption
- Insufficient
- Hype gap+34
- Incentives72
- Confidence46